Perception of bronchodilation in subjects with asthma and smokers with airflow limitation

Respirology

Volumn 4, Issue 2, 1999, Pages 117-124

  Salome, Cheryl M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asthma; Bronchodilator response; Perception; Smoking

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL;

ADULT; AIRWAY CONDUCTANCE; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHODILATING ACTIVITY; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; LUNG VOLUME; PRIORITY JOURNAL; SMOKING; SPIROMETRY;

EID: 0033064303     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.1999.00162.x     Document Type: Article

References (24)

1. Woolcock AJ, Rubinfield AR, Scale JP et al. Thoracic Society of Australia and New Zealand. Asthma management plan, 1989. Med. J. Aust. 1989; 151: 650-3.
2. British Thoracic Society. Guidelines for management of asthma in adults: I - chronic persistent asthma. BMJ 1990; 301: 651-3.
3. National Heart Lung and Blood Institute. International consensus report on diagnosis and treatment of asthma. Eur. Respir. J. 1992; 5: 601-41.
4. Jenkins C, Mitchell C, Irving L, Frith P, Young I. Guidelines for the management of chronic obstructive pulmonary disease. Mod. Med. Aust. 1995; 38: 132-46.
5. Christmas T, Kolbe J. COPD: The role of drug therapy. Curr. Therapeutics 1994; 35: 69-74.
6. Orehek J, Beaupre A, Badier M, Nicoli MM, Delpierre S. Perception of airway tone by asthmatic patients. Bull. Eur. Physiopath. Resp. 1982; 18: 601-7.
7. Noseda A, Schmerber J, Prigogine T, Yernault JC. How do patients with either asthma or COPD perceive acute bronchodilation? Eur. Respir. J. 1993; 6: 636-44.
8. Bellamy D, Hutchison DCS. The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema. Br. J. Dis. Chest 1981; 75: 190-6.
9. Woolcock AJ, Read J. Lung volumes in exacerbations of asthma. Am. J. Med. 1966; 41: 259-73.
10. Siafakas NM, Vermiere P, Pride NB et al. Optimal assessment and management of chronic obstructive pulmonary disease. Eur. Respir. J. 1995; 8: 1398-420.
11. Barros MJ, Rees PJ. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Respir. Med. 1990; 84: 371-5.
12. Petty TL. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter study. Chest 1994; 105: 1411-19.
13. Pepys J. Types of allergic reaction. Clin. Allergy 1973; 3: S491-509.
14. Simon PM, Schwartzstein RM, Weiss JW et al. Distinguishable sensations of breathlessness induced in normal volunteers. Am. Rev. Respir. Dis. 1989; 140: 1021-7.
15. Lewis RA, Lewis MN, Tattersfield AE. Asthma induced by suggestion: Is it due to airway cooling? Am. Rev. Respir. Dis. 1984; 129: 691-5.
16. Ilfeld FW. Further validation of a psychiatric symptom index in a normal population. Psychol. Rep. 1976; 39: 1215-28.
17. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 1981; 123: 659-64.
18. Crapo RO, Morris AH, Clayton PO, Nixon CR. Lung volumes in healthy non-smoking adults. Bull. Eur. Physiopath. Resp. 1982; 18: 419-25.
19. Braun SR, Levy SF, Grossman J. Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: A three-center study. Am. J. Med. 1991; 91 (Suppl. 4A): S28-32.
20. Eliasson O, Degraff AC Jr. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Am. Rev. Respir. Dis. 1985; 132: 858-64.
21. Kesten S, Rebuck AS. Is the short-term response to inhaled β-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest 1994; 105: 1042-5.
22. Lougheed MD, Lam M, Forkert L, Webb KA, O'Donnell DE. Breathlessness during acute bronchoconstriction in asthma. Am. Rev. Respir. Dis. 1993; 148: 1452-9.
23. Rubinfield AR, Pain MCE Perception of asthma. Lancet 1976; 1: 882-4.
24. Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self-management plans for the control of asthma in general practice. BMJ 1990; 301: 1355-9.